10-Q: Concentra Q1 2026 Financial Results

Concentra Group Holdings reported strong Q1 2026 growth with revenue rising 13.7% to $569.6 million, driven by increased patient volumes and strategic acquisitions.

Summary

• Revenue increased 13.7% year-over-year to $569.6 million for the first quarter of 2026.
• Net income rose to $52.3 million, compared to $40.6 million in the same period of 2025.
• Total patient visits grew 6.7% to 3.4 million, with workers compensation visits up 9.6%.
• Segment Adjusted EBITDA reached $120.7 million, up from $102.7 million in Q1 2025.
• Earnings per share (EPS) for the quarter was $0.39, compared to $0.30 in Q1 2025.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong performance, characterized by solid revenue growth and improved operational efficiency, despite ongoing legal headwinds.

Positives

• Revenue growth of 13.7% reflects successful organic expansion and integration of recent acquisitions.
• Operating margin improved as cost of services decreased to 70.1% of revenue from 71.3% in the prior year period.
• Strong cash flow from operations provided $21.0 million, supporting capital allocation strategies.
• Successful execution of share repurchase program, retiring 0.7 million shares for $15.0 million during the quarter.
• Maintained a healthy leverage ratio of 3.4x, well within the 6.5x covenant limit.

Negatives

• General and administrative expenses increased as a percentage of revenue to 9.7% from 9.3%, reflecting costs associated with operating as an independent public company.
• Cash balance decreased to $61.7 million from $79.9 million at year-end 2025, largely due to share repurchases and dividend payments.
• Interest expense remains a significant burden at $26.0 million for the quarter.

Risks

• Ongoing legal and regulatory investigations, including a California whistleblower qui tam lawsuit and a California Department of Insurance investigation regarding billing practices.
• Potential material impact from consolidated class action lawsuits related to the Perry Johnson & Associates data breach.
• Exposure to interest rate volatility on variable-rate debt, despite current hedging instruments.
• Reliance on third-party payors and potential changes to state workers compensation fee schedules.
• Risks associated with integrating acquisitions and managing a large network of onsite health clinics.

Future Outlook

The company continues to focus on growth through strategic acquisitions of occupational health centers and onsite health clinic platforms, alongside the development of new de novo centers. Management believes existing cash flows and borrowing capacity are sufficient to support operations and strategic initiatives.

Management Comments

• Management emphasizes that the number of patient visits is the single most important indicator of service volume.
• The company maintains that it is the largest provider of occupational health services in the U.S. by number of locations.
• Management believes that the current insurance coverage and risk management programs are appropriate, though significant legal actions could still pose risks.

Industry Context

StockSavvy.ai notes that Concentra is leveraging its scale as the largest U.S. occupational health provider to capture market share in the fragmented employer-sponsored healthcare space. The shift toward onsite clinics reflects a broader industry trend of employers seeking to control healthcare costs and improve employee wellness directly at the worksite.

Comparison to Industry Standards

• Concentra's growth in onsite clinics (411 locations) positions it as a dominant player compared to smaller regional occupational health providers.
• The company's focus on workers compensation (65% of visit-related revenue) aligns with industry leaders in the occupational medicine sector.
• The use of Segment Adjusted EBITDA is consistent with standard reporting practices for healthcare services companies.

Corporate Governance

Legal Proceedings

• California whistleblower qui tam lawsuit regarding physical therapy referral guidelines.
• California Department of Insurance investigation into billing and coding practices.
• Consolidated class action litigation related to the Perry Johnson & Associates data breach.
• U.S. Department of Justice investigation into physical therapy billing practices.

Related Party Transactions

• Transition services agreement with Select Medical Corporation for shared support functions including finance, HR, and IT.

Stakeholder Impact

• Shareholders benefit from dividend payments and share repurchases.
• Employees and patients are impacted by ongoing data breach litigation and potential changes to service delivery models.
• Creditors remain protected by the company's adherence to leverage covenants.

Next Steps

• Continue integration of Pivot Onsite Innovations.
• Monitor and defend against ongoing legal proceedings and investigations.
• Execute remaining $65 million share repurchase authorization.
• Distribute cash dividend on or about June 9, 2026.

Key Dates

Recommendation

While the company shows strong operational growth and solid cash flow, the significant legal and regulatory uncertainties, including multiple investigations and class action lawsuits, warrant a cautious 'hold' approach until these matters reach a clearer resolution.

Keywords

Concentra, occupational health, workers compensation, onsite health clinics, healthcare services, 10-Q, financial results